MedTrace Logo

Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension

NCT02269176 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2014-10-21

No results posted yet for this study

Summary

Using Losartan as a comparator, to evaluate the efficacy and safety of telmisartan in the treatment of the mild to moderate primary hypertension patients in China

Conditions

Interventions

DRUG

Low dose of telmisartan

DRUG

High dose of telmisartan

DRUG

Low dose of losartan

DRUG

High dose of losartan

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-07-31
Primary Completion
2001-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02269176 on ClinicalTrials.gov